Dr RR Baliga's "Got Knowledge Doc" Podkast

A fascinating Lancet RCT shows once-weekly semaglutide may redefine alcohol use disorder treatment. 🎯   In 108 adults with AUD and obesity, semaglutide reduced heavy drinking days by –13.7 percentage points vs placebo (p=0.0015) and improved craving, consumption, and biomarkers. 📉   With an NNT of ~4.3 and a manageable safety profile, GLP-1 therapy signals a shift from abstinence to precision ha...

What does it take to be remembered for 3,000 years? 🏺   Meet Imhotep —chancellor, architect of the Step Pyramid, and later revered as a god of healing. From stone structures that defy time to ideas that shaped medicine and myth, his legacy is both historical and philosophical.   As highlighted in early narratives, he was not just a builder of monuments—but a builder of meaning.    A timeless remi...

❤️ New in Circulation : the 2026 AHA Dietary Guidance to Improve Cardiovascular Health distills prevention into 9 elegant features—maintain healthy weight, emphasize vegetables/fruits, choose whole grains, favor healthier proteins and unsaturated fats, minimize ultraprocessed foods, added sugars, and sodium, and avoid starting alcohol for health. Food, here, is not garnish; it is strategy. 🥗🌾🩺...

🧬⚠️ Genes. Toxins. Tumors.   A compelling Nature Medicine study uncovers how the exposome—our lifetime environmental exposures—leaves epigenetic fingerprints linked to early-onset colorectal cancer .   🚜 A striking signal: picloram exposure shows consistent association across cohorts and real-world US data. 📊 Reinforces known risks (smoking, diet, education) while revealing novel environmental...

Can AI think like a physician? 🧠🤖   A landmark Science 2026 study shows LLMs outperform physicians in structured diagnostic reasoning across NEJM cases and real-world emergency scenarios. 📊   Accuracy gains were striking—especially in early triage where uncertainty is highest. Yet, the story is not replacement, but partnership. 🤝   The real challenge now: translating benchmark brilliance into...

A quiet revolution in tuberculosis diagnostics is here. 🧪🌍   This NEJM study shows that MiniDock MTB , a rapid swab-based molecular test, delivers Xpert-level accuracy with minimal training and no adverse events —all in a near–point-of-care format. ⏱️🧠   Key insights: 🔹 Sensitivity: 85.7% (sputum), 79.6% (tongue) 🔹 Specificity: >97–99% 🔹 Strong performance vs smear microscopy (+24% sensitivi...

A meal may be more than nutrition—it may be immunotherapy. 🍽️⚡ In a striking Nature study, T cells sampled just 6 hours after feeding showed enhanced metabolic fitness, cytokine production, and persistence compared to the fasted state. 🧠🔥 Mechanistically, chylomicron-derived lipids → LDLR → mTORC1 → protein translation , fueling durable immune function. Even more compelling: postprandial CAR-T...

BP Lowering in CKD: Consistent. Comprehensive. Compelling. 📉🫀 A landmark individual-participant meta-analysis (285K+ patients) shows that every 5 mm Hg reduction in systolic BP reduces major cardiovascular events by ~10%—across all CKD stages. Key insight: the benefit holds even at lower BP levels and across drug classes. ⚖️ But in CKD + diabetes, the effect attenuates—reminding us that biology...

🌿 Balance. Body. Beginnings. Long before modern medicine spoke of personalization and prevention, Charaka articulated a remarkably sophisticated vision of health—rooted in balance, biology, and behavior. From the Charaka Samhita to the concept of doshas (vata, pitta, kapha) , his work reflects an early systems-based approach that continues to echo in today's precision and lifestyle medicine. This...

⚡🫀 Shock. Silence. Success — A landmark New England Journal of Medicine trial redefines first-line therapy in persistent AF.   In AVANT GUARD, pulsed field ablation (PFA) outperformed antiarrhythmic drugs: 📊 Success: 56% vs 30% 📉 HR: 0.46 (P

A fascinating Science (2026) study reveals why the heart is remarkably resistant to cancer. Mechanical load—through contraction and pressure—suppresses tumor proliferation via epigenetic remodeling.  Unloading the heart doubled cancer cell proliferation, while load reduced histone methylation and chromatin compaction through Nesprin-2–mediated mechanotransduction. A striking paradigm: the beating...

A simple idea, executed elegantly.   In the NEJM TRIDENT trial , a single low-dose triple antihypertensive pill reduced recurrent stroke after intracerebral hemorrhage (HR 0.61) and improved BP control (50% vs 26%).   Yet, only half reached target—reminding us that pills alone don't solve therapeutic inertia.   The message is clear: simplify treatment, intensify targets, and build systems that ens...

A pivotal JAMA randomized trial introduces an epigenetic twist to frontline therapy in high-risk DLBCL. Adding tucidinostat (HDAC inhibitor) to R-CHOP improved event-free survival (HR 0.72, P=0.02) and increased complete response rates (73% vs 62%) in MYC/BCL2 double-expressor lymphoma. Toxicity was higher but manageable.   A quiet but meaningful shift—targeting biology, not just burden.   #DLBCL...

A pragmatic Lancet RCT (SCOUT) reshapes UTI management. In 768 women, nitrofurantoin achieved the highest clinical resolution at day 7 (74%) vs single-dose fosfomycin (59%), with a significant 15.5% absolute difference. Pivmecillinam and two-dose fosfomycin performed intermediately. Adverse events were mild across groups.   The message is clear: convenience may cost efficacy. Short-course regimens...

A large nationwide cohort study in JAMA compared amoxicillin-clavulanate vs amoxicillin for acute sinusitis in >500,000 adults. Treatment failure was low (~3%) with no significant difference between groups (RR 0.96). However, broader-spectrum therapy increased secondary infections, including yeast and C. difficile .   The message is clear: narrow-spectrum amoxicillin remains a rational first-line...

A quiet revolution in medicine began not in a laboratory—but in a dialogue. 🌿   Punarvasu Atreya, one of the earliest architects of Ayurveda, transformed healing into a disciplined science through teaching, inquiry, and debate. His legacy—preserved in the Charaka Samhita and Bhela Samhita —shaped centuries of clinical reasoning and holistic care.   From Takshashila to modern medicine, his influen...

A thoughtful, practice-shaping study in NEJM explores a long-standing clinical dilemma: can we truly move the needle in post-thrombotic syndrome?   The C-TRACT trial shows that endovascular therapy (iliac-vein stenting) significantly improves symptom burden and quality of life in patients with moderate–severe disease—measured rigorously using VCSS, VEINES-QOL, and SF-36. The magnitude of benefit i...

A landmark study in the New England Journal of Medicine shows that hypertension control is no longer just about prescribing medications—it's about systems, teams, and sustained engagement . 🩺📊   In a cluster-randomized trial across underserved populations, a multifaceted, team-based strategy —combining protocol-driven care, health coaching, and home BP monitoring—achieved a significant additiona...

Sex hormones shape cardiovascular risk in subtle yet powerful ways. From estrogen-driven changes in coagulation to formulation-specific differences in VTE risk, the nuance matters. Transdermal estradiol offers a safer path, while ethinyl estradiol reminds us that dose and route are destiny. The key is not avoidance—but precision: matching therapy to individual risk.   Three takeaways: • Formulatio...

  A landmark JAMA study on transcatheter tricuspid valve replacement (TTVR) offers compelling real-world evidence 🫀   ✅ 98.4% procedural success ✅ Near-complete TR elimination (97.7% at 30 days) ✅ Significant improvement in symptoms & quality of life ⚠️ Trade-off: ~16% new pacemaker rate in device-naïve patients   In an elderly, high-risk cohort, TTVR delivers what surgery often cannot— restor...

  A quiet shift, yet a profound one. 🧠   The OCEANIC-STROKE trial introduces asundexian , a Factor XIa inhibitor that lowers recurrent ischemic stroke risk (HR 0.74) without increasing major bleeding—a long-sought balance in antithrombotic therapy.   For decades, we traded efficacy for safety. Now, we may finally have both. ⚖️   The implications extend beyond stroke—to a broader rethinking of thr...

  🧠 Brain metastases remain a clinical frontier—common, complex, and still lethal. In Science Signaling , Chafe et al. unpack the biology: Blood Brain Barrier traversal, metabolic rewiring, and immune evasion.   Key insight: metastasis is not just spread—it is adaptation.   From adenosine-driven immunosuppression to neuronal-like tumor states, new therapeutic doors are opening.   Precision oncolo...

What if the roots of modern surgery were written over 2,000 years ago? 🩺📜   Meet Suśruta —a pioneer whose Suśruta Saṃhitā laid the foundations of plastic surgery, cataract procedures, and structured medical training. From rhinoplasty to hands-on simulation using natural models, his approach was remarkably ahead of its time.   A reminder that innovation is often rediscovery—and that the future of...

  🧠💊 Stop. Test. Rethink.   A compelling new study in JAMA shows that ~26% of adults ≥60 years can safely discontinue levothyroxine , maintaining normal thyroid function—especially those on low doses (≤50 μg/day) .   📉 No meaningful decline in quality of life 📊 Clear dose-response signal ⚠️ Raises concerns about lifelong overtreatment   The message is elegant: Not every prescription deserves p...

A fascinating step forward in Nature —where immunology meets cardiology. 🧬❤️   This study shows that engineered dendritic cells can locally reprogram the immune response , reduce fibrosis, and improve cardiac function—without systemic immunosuppression.   The insight is simple, yet profound: 👉 Heart failure is not just hemodynamic—it is immunologic.   From FAP-targeted delivery to checkpoint-med...